Logo image of NEOV

NEOVOLTA INC (NEOV) Stock Fundamental Analysis

NASDAQ:NEOV - Nasdaq - US6406551068 - Common Stock - Currency: USD

2.28  +0.09 (+4.11%)

After market: 2.35 +0.07 (+3.07%)

Fundamental Rating

3

Taking everything into account, NEOV scores 3 out of 10 in our fundamental rating. NEOV was compared to 97 industry peers in the Electrical Equipment industry. The financial health of NEOV is average, but there are quite some concerns on its profitability. NEOV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NEOV has reported negative net income.
In the past year NEOV has reported a negative cash flow from operations.
NEOV had negative earnings in each of the past 5 years.
NEOV had a negative operating cash flow in each of the past 5 years.
NEOV Yearly Net Income VS EBIT VS OCF VS FCFNEOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

NEOV has a worse Return On Assets (-80.99%) than 82.47% of its industry peers.
The Return On Equity of NEOV (-98.60%) is worse than 60.82% of its industry peers.
Industry RankSector Rank
ROA -80.99%
ROE -98.6%
ROIC N/A
ROA(3y)-76.82%
ROA(5y)-101.61%
ROE(3y)-104.1%
ROE(5y)-119.8%
ROIC(3y)N/A
ROIC(5y)N/A
NEOV Yearly ROA, ROE, ROICNEOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

NEOV has a Gross Margin of 23.77%. This is comparable to the rest of the industry: NEOV outperforms 51.55% of its industry peers.
In the last couple of years the Gross Margin of NEOV has grown nicely.
NEOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.68%
GM growth 5YN/A
NEOV Yearly Profit, Operating, Gross MarginsNEOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

NEOV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NEOV has more shares outstanding
NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NEOV Yearly Shares OutstandingNEOV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NEOV Yearly Total Debt VS Total AssetsNEOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 52.34 indicates that NEOV is not in any danger for bankruptcy at the moment.
NEOV's Altman-Z score of 52.34 is amongst the best of the industry. NEOV outperforms 98.97% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that NEOV is not too dependend on debt financing.
The Debt to Equity ratio of NEOV (0.12) is better than 65.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 52.34
ROIC/WACCN/A
WACCN/A
NEOV Yearly LT Debt VS Equity VS FCFNEOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 12.02 indicates that NEOV has no problem at all paying its short term obligations.
The Current ratio of NEOV (12.02) is better than 95.88% of its industry peers.
NEOV has a Quick Ratio of 5.94. This indicates that NEOV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NEOV (5.94) is better than 92.78% of its industry peers.
Industry RankSector Rank
Current Ratio 12.02
Quick Ratio 5.94
NEOV Yearly Current Assets VS Current LiabilitesNEOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NEOV have decreased strongly by -72.49% in the last year.
NEOV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.28%.
The Revenue for NEOV have been decreasing by -18.13% on average. This is quite bad
EPS 1Y (TTM)-72.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.85%
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-18.13%
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

The Earnings Per Share is expected to grow by 34.42% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 105.50% on average over the next years. This is a very strong growth
EPS Next Y-57.14%
EPS Next 2Y41.42%
EPS Next 3Y34.42%
EPS Next 5YN/A
Revenue Next Year71.43%
Revenue Next 2Y155.65%
Revenue Next 3Y105.5%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEOV Yearly Revenue VS EstimatesNEOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEOV Yearly EPS VS EstimatesNEOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2027 0 -0.05 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NEOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEOV Price Earnings VS Forward Price EarningsNEOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEOV Per share dataNEOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

NEOV's earnings are expected to grow with 34.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y34.42%

More info and screens

0

5. Dividend

5.1 Amount

NEOV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOVOLTA INC

NASDAQ:NEOV (4/24/2025, 8:00:02 PM)

After market: 2.35 +0.07 (+3.07%)

2.28

+0.09 (+4.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-07 2025-02-07/amc
Earnings (Next)N/A N/A
Inst Owners17.23%
Inst Owner Change0.63%
Ins Owners15.12%
Ins Owner Change0%
Market Cap76.20M
Analysts82.86
Price Target7.65 (235.53%)
Short Float %4.99%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.55%
Min EPS beat(2)-47.06%
Max EPS beat(2)1.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)41.25%
Min Revenue beat(2)-27.7%
Max Revenue beat(2)110.2%
Revenue beat(4)1
Avg Revenue beat(4)-7.7%
Min Revenue beat(4)-94.43%
Max Revenue beat(4)110.2%
Revenue beat(8)2
Avg Revenue beat(8)-23.19%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-38.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.18
P/FCF N/A
P/OCF N/A
P/B 23.09
P/tB 23.09
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.08
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.99%
ROE -98.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.77%
FCFM N/A
ROA(3y)-76.82%
ROA(5y)-101.61%
ROE(3y)-104.1%
ROE(5y)-119.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.68%
GM growth 5YN/A
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.02
Quick Ratio 5.94
Altman-Z 52.34
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.85%
EPS Next Y-57.14%
EPS Next 2Y41.42%
EPS Next 3Y34.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-18.13%
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next Year71.43%
Revenue Next 2Y155.65%
Revenue Next 3Y105.5%
Revenue Next 5YN/A
EBIT growth 1Y-66.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.33%
EBIT Next 3Y40.86%
EBIT Next 5YN/A
FCF growth 1Y-43.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.37%
OCF growth 3YN/A
OCF growth 5YN/A